These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
59 related items for PubMed ID: 19819062
1. Potential of mean force of the hepatitis C virus core protein-monoclonal 19D9D6 antibody interaction. Wang YT, Su ZY, Chen CL. Biophys Chem; 2009 Dec; 145(2-3):86-90. PubMed ID: 19819062 [Abstract] [Full Text] [Related]
2. Potential of mean force for Syrian hamster prion epitope protein--monoclonal fab 3f4 antibody interaction studies. Wang YT, Su ZY, Liao JM, Chen CL. Eur J Med Chem; 2009 Sep; 44(9):3504-8. PubMed ID: 19304354 [Abstract] [Full Text] [Related]
3. Binding hot-spots in an antibody-ssDNA interface: a molecular dynamics study. Wang YT, Lee WJ. Mol Biosyst; 2012 Oct 30; 8(12):3274-80. PubMed ID: 23079742 [Abstract] [Full Text] [Related]
8. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. Moradpour D, Wakita T, Tokushige K, Carlson RI, Krawczynski K, Wands JR. J Med Virol; 1996 Mar 30; 48(3):234-41. PubMed ID: 8801283 [Abstract] [Full Text] [Related]
9. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system. Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W. Mol Immunol; 2006 Feb 30; 43(5):436-42. PubMed ID: 16337486 [Abstract] [Full Text] [Related]
10. Core protein-nucleic acid interactions in hepatitis C virus as revealed by Raman and circular dichroism spectroscopy. Rodríguez-Casado A, Molina M, Carmona P. Appl Spectrosc; 2007 Nov 30; 61(11):1219-24. PubMed ID: 18028701 [Abstract] [Full Text] [Related]
12. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen. León P, López JA, Elola C, Lee SR, Calmann M, Echevarría JM. Vox Sang; 1998 Nov 30; 75(1):32-6. PubMed ID: 9745151 [Abstract] [Full Text] [Related]
14. Nucleotide sequences of the hepatitis C virus core region in patients without anti-core antibody. Nagasaka A, Hige S, Kurosawa M, Yoshida J, Karino Y, Toyota J, Matsushima T, Asaka M. J Med Virol; 1996 Jun 30; 49(2):91-4. PubMed ID: 8991942 [Abstract] [Full Text] [Related]
15. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule]. Tan W, Lang Z, Cong Y, Chen G, Miao J, Zhan M. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 30; 11(3):205-7. PubMed ID: 15617329 [Abstract] [Full Text] [Related]
18. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J. Hepatology; 1999 Apr 30; 29(4):1288-98. PubMed ID: 10094977 [Abstract] [Full Text] [Related]
19. [Recombinant antibodies in serologic diagnosis]. Wölpl A, Cardoso M, Siemoneit K, Koerner K, Kubanek B. Beitr Infusionsther; 1993 Apr 30; 31():147-51. PubMed ID: 7693244 [Abstract] [Full Text] [Related]